Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part IV

February 23, 2015 updated by: University of Alabama at Birmingham

Randomized Evaluation of the Use of Plastic Bags to Prevent Neonatal Hypothermia in Developing Countries-Part IV

The overall hypothesis is that plastic bags used in combination with WHO thermoregulation care will reduce the incidence of hypothermia in preterm/low birth weight and full term infants when compared to routine WHO thermoregulation care alone. Part V is comparing use of a plastic torso wrap to no plastic torso wrap in preterm/low birth weight infants following removal from their incubator to assist with temperature regulation.

Study Overview

Detailed Description

Due to limited resources and numbers of incubators, hospitals in developing countries remove infants from incubators at lower weights than in developed countries, putting infants at increased risk for hypothermia. This study will compare the incidence of hypothermia during the 72 hours after incubator removal of infants randomized to receive standard incubator removal (control group) or standard incubator removal with a plastic bag covering their torsos and lower extremities (intervention group). The axillary temperature of each infant will be taken upon removal from the incubator, every subsequent 6-8 hours, and finally, at 72 hours as the bags are removed. Blood pressure, blood sugar, seizures, weight gain, hyperthermia, death, observation for respiratory distress, bronchopulmonary dysplasia, sepsis, intraventricular hemorrhage, periventricular leukomalacia, necrotizing enterocolitis, intestinal perforation, pulmonary hemorrhage room temperature and humidity, and length of time in an incubator will be recorded throughout their hospitalization for all infants. With an estimated hypothermia incidence of 30% and a hypothesized 20% absolute risk reduction (66% relative risk reduction), a sample size of 118 will be used to have a power of 80% and a confidence interval of 95%.

Study Type

Interventional

Enrollment (Actual)

118

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lusaka, Zambia
        • University Teaching Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 hour to 3 days (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Infant admitted to the NICU
  • Current weight less than 2,000g
  • Being removed from incubator

Exclusion Criteria:

  • Abdominal wall defect or myelomeningocele
  • Major congenital anomalies
  • Blistering skin disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Incubator removal-torso bag
Use plastic bag covering the torso and lower extremities for temperature regulation with standard bundling practices when removing infant from incubator
Upon removal from the incubator, infant will be placed into a plastic bag to his/her axillae, and the bag will be folded and taped to itself to prevent it from covering the infant's nose or mouth. The infant will be wrapped in a blanket and receive a cloth hat. The bag will be changed when soiled and the infant will remain in the bag for 72 hours or until discharge, whichever comes first. The infant's temperature will be monitored for 72 hours or until discharge, whichever comes first.
Placebo Comparator: Incubator removal-no plastic bag
Standard bundling practices when removing the infant from the incubator. No plastic bag used.
Upon removal from incubator, the infant will be wrapped in a blanket and receive a cloth hat, according to standard bundling practices. The infant's temperature will be monitored for 72 hours or until discharge, whichever comes first.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Axillary temperature 36.5-37.5 degrees Celsius
Time Frame: 1-72 hours
Temperature taken per axilla for one minute
1-72 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory Distress Syndrome (RDS)
Time Frame: Up to 4 weeks
Documentation of increased work of breathing, retractions, and a need for oxygen, intubation, or surfactant
Up to 4 weeks
Pneumothorax
Time Frame: Up to 4 weeks
Either chest radiograph documentation or clinical deterioration consistent with air leak
Up to 4 weeks
Sepsis
Time Frame: Up to 4 weeks
Culture proven or culture negative clinically treated course consistent with sepsis
Up to 4 weeks
Death
Time Frame: Up to 4 weeks
Cardiorespiratory failure
Up to 4 weeks
Necrotizing enterocolitis or intestinal perforation
Time Frame: Up to 4 weeks
Documentation of pneumatosis or intestinal perforation on x-ray or treatment course for clinical necrotizing enterocolitis per Bell's Classification stage greater than 1.
Up to 4 weeks
Blood pressure
Time Frame: Up to 4 weeks
Measure of extremity blood pressure per cuff taken during nursery stay
Up to 4 weeks
Blood glucose
Time Frame: Up to 4 weeks
Measure of blood glucose per laboratory value taken per heel stick
Up to 4 weeks
Seizure
Time Frame: Up to 4 weeks
Seizure activity diagnosed by medical doctor or nurse. No electoencephalogram will be done.
Up to 4 weeks
Weight gain
Time Frame: Up to 4 weeks
Infant will be weighed daily and rates of weight gain will be calculated
Up to 4 weeks
Bronchopulmonary Dysplasia (BPD)
Time Frame: 28 days after birth
Oxygen requirement at 28 days of life
28 days after birth
Major brain injury
Time Frame: Up to 4 weeks
Intracranial hemorrhage grade 3-4 or periventricular leukomalacia documented on cranial ultrasound
Up to 4 weeks
Pulmonary hemorrhage
Time Frame: Up to 4 weeks
Blood seen in the endotracheal tube and treated by physician
Up to 4 weeks
Hyperthermia
Time Frame: Up to 4 weeks
Axillary temperature > 38 degrees Celsius per temperature taken per axilla for 1 minute
Up to 4 weeks
Length of time in incubator
Time Frame: Up to 4 weeks
Documentation of length of time spent in incubator and number of times placed in incubator
Up to 4 weeks
Room temperature and humidity
Time Frame: 1-72 hours
A recording of the room temperature and humidity will be obtained with each axillary temperature measurement
1-72 hours
Incubator temperature and humidity
Time Frame: 1 hour
A recording of the air temperature and humidity with the incubator will be obtained with each axillary temperature measurement
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2012

Primary Completion (Actual)

August 1, 2014

Study Completion (Actual)

February 1, 2015

Study Registration Dates

First Submitted

May 21, 2012

First Submitted That Met QC Criteria

May 21, 2012

First Posted (Estimate)

May 23, 2012

Study Record Updates

Last Update Posted (Estimate)

February 24, 2015

Last Update Submitted That Met QC Criteria

February 23, 2015

Last Verified

February 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UAB Neo 009

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypothermia

Clinical Trials on Hypothermia prevention with plastic bag

3
Subscribe